TP53 and neoplasm: Furthermore, due to chronic inflammation, somatic mutations may occur in cells infected by HBV, which may interfere with tumor suppression pathways, such as mutations in the TP53, Axin1, and RB1 genes, or even favor the expression of oncogenes such as CTNNB1, or interfere with cellular resistance to oxidative stress (KEAP1) [137].